Zealand Pharma
833.5
DKK
-5.01 %
ZEAL
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
17 following
www.zealandpharma.com
Zealand Pharma is a biotechnology company. Particular focus is found in the development of drugs for the treatment of diabetes and various intestinal diseases. The company has a varied product portfolio with separate brands that are sold on a global level. The largest business is in the Nordic market. Zealand Pharma was founded in 1997 and is headquartered in Söborg, Denmark.
Revenue
342.79M
EBIT %
-166.94 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Copenhagen
ZEAL
Daily low / high price
833.5 / 881
DKK
Market cap
59.2B DKK
Turnover
166.31M DKK
Volume
196K
Latest videos
Financial calendar
Annual report
20.02.2025
Interim report
08.05.2025
Interim report
14.08.2025
Interim report
06.11.2025
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Van Herk Investments | 16.8 % | 16.8 % |
| Credit Suisse Group AG | 6.2 % | 6.2 % |
ShowingAll content types
Zealand Pharma Announces Financial Results for the First Nine Months of 2024
Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinism
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools